Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Heart, Lung, and Blood Institute seeks a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. This study focuses on transthyretin variants in sickle cell disease, requiring standardized sample processing and delivery of normalized datasets. Interested parties may submit capability statements to demonstrate their qualifications.
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. The requirement supports a longitudinal study investigating transthyretin (TTR) variants in sickle cell disease severity and includes quantification of over 5,400 proteins per sample. Services include standardized sample processing, assay execution, quality control, and delivery of normalized datasets compatible with previously generated study data. This notice is issued as a Notice of Intent for a non-competitive award; however, interested parties may submit capability statements demonstrating their ability to meet the Government’s requirement.
NOI - OLINK EXPLORE HT PROTEOMIC ANALYSIS FOR SICKLE CELL DISEASE STUDY is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.